Hendrik Schmidt—picture alliance/Getty Images
Company Information
As of 8/3/2022
Country
Germany
Headquarters
Leverkusen, Germany
Industry
Pharmaceuticals
CEO
Werner Baumann
Website
Company Type
Public
Ticker
BAYRY
Revenues ($M)
$52,118.4
Profits ($M)
$1,182.3
Market Value ($M)
$58,203
Employees
99,637
Figures prepared in accordance with International Accounting Standards. Market value as of July 19, 2022.
Key Financials (Last Fiscal Year)As of 8/3/2022
($ Millions)
% change
Revenues ($M)
$52,118.4
7.5%
Profits ($M)
$1,182.3
-
Assets ($M)
$136,714
-
Total Stockholder Equity ($M)
$37,543.7
-
Profit RatiosAs of 8/3/2022
Profit as % of Revenues
2.3%
Profits as % of Assets
0.9%
Profits as % of Stockholder Equity
3.1%
Bayer Rank History
Historical Data
Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
---|---|---|---|---|
2021 | $48,483.6-6.4% | $-11,958.5-361.2% | $143,240.9 | $37,355.3 |
2020 | $51,80710.9% | $4,578.9128.9% | $141,712 | $53,131 |
2019 | $46,718.1-10% | $2,000.4-75.8% | $144,343.8 | $52,551.7 |
2018 | $51,933-1.2% | $8,269.365% | $90,162.1 | $44,189.5 |
2017 | $52,5690.3% | $5,010.69.9% | $86,731 | $31,990 |
SHOW MORE
Lists ranking Bayer
Latest news for Bayer
- Newsletters
Shareholders are forcing Bayer’s CEO out. What do they expect from his replacement?March 10, 2023, 4:05 PM UTC - Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021August 15, 2022, 10:15 PM UTC - Health
CureVac scraps its first-generation COVID-19 vaccine candidate, shares tumbleOctober 12, 2021, 12:34 PM UTC
- The emerging CFO: Future finance leaders conversation;42:32ConferencesÂ;
- Bayer CEO on Resochin donations and Roundup settlement talks during COVID-19 crisis;7:43Series, On LeadingÂ;
- Bayer CEO: 'This Was the Best Lesson Ever';2:19Series, On LeadingÂ;
- Is Bayer Still a Buyer?;2:59Series, On LeadingÂ;